Electra Therapeutics clinical trials we track

Check company identity source

Phase 2 / 3 1 trial

TrialDrugs studiedStatusPrimary completion
Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)NCT05416307ELA026Recruiting2028-03Estimated

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters